{"doi":"10.1016/j.yebeh.2025.110853","title":"Unique quality of life priorities for people with epilepsy and comorbid functional seizures","abstract":"OBJECTIVE: Epileptic seizures (ES) and functional seizures (FS) commonly coexist. People with both conditions (ES + FS) report different contributing factors to quality of life (QOL) compared to people with ES only. However, a distinct core outcome set (COS) for measuring QOL among people with ES + FS does not exist. METHODS: We analyzed cross-sectional data from an existing Delphi consensus study that defined a QOL COS for adults with self-reported epilepsy with or without comorbid FS. Participants assigned importance rankings via a 9-point Likert scale to 248 QOL outcomes. A potential COS inclusion list was identified via established consensus thresholds. Differences in QOL priorities between those with and without comorbid FS were evaluated by Wilcoxon rank-sum tests. RESULTS: Of 291 adults with epilepsy, 269 had ES and 22 had ES + FS. People with ES + FS assigned critical importance to more QOL outcomes across a wider range of domains, particularly in functional, psychiatric, and healthcare utilization areas. 38 QOL outcomes were rated as critically important for potential inclusion in a COS for people with ES + FS. There were differences in QOL priorities between groups, with people with ES + FS assigning higher importance to having questions on \"having thoughts of suicide\" and items related to high-acuity, frequent, and prolonged encounters with the healthcare system. SIGNIFICANCE: Measuring QOL in people with ES + FS, who assigned greater importance to suicidal ideation and healthcare utilization items, requires an overlapping but distinct COS when compared to people with ES.","journal":"Epilepsy & Behavior","year":2025,"id":584365,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.7585,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":477801,"name":"Robert Moss","orcid":"0000-0002-9407-5681","position":1,"is_corresponding":false},{"id":259359,"name":"Vikram R. Rao","orcid":"0000-0002-6389-2638","position":2,"is_corresponding":false},{"id":477799,"name":"Sharon Chiang","orcid":"0000-0002-4548-4550","position":3,"is_corresponding":false},{"id":1497199,"name":"Kathleen L. Cui","orcid":"0009-0001-0685-052X","position":0,"is_corresponding":true}],"reference_count":55,"raw_metadata":null,"created_at":"2026-07-19T02:59:11.978098Z","pmid":"41353871","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}